Chromatographia

, Volume 71, Issue 1–2, pp 71–77 | Cite as

Simultaneous RP-LC Analysis of Diltiazem and Non-Steroidal Anti-Inflammatory Drugs in Pharmaceutical Formulations and Human Serum

  • Najma Sultana
  • M. Saeed Arayne
  • Nighat Shafi
  • Farhan A. Siddiqui
Original
First Online:
Received:
Revised:
Accepted:

Abstract

A simple, precise, accurate, selective, and sensitive reversed-phase LC–UV method has been developed for simultaneous analysis of diltiazem and non-steroidal anti-inflammatory drugs (NSAIDs) in the bulk drug, tablet dosage forms, and human serum. Chromatographic separation of the drugs was performed at ambient temperature on a C18 stationary phase with 80:20 (v/v) methanol–water, pH 3.1 ± 0.02, as isocratic mobile phase. The mobile phase flow rate was initially 0.5 mL min−1 then increased to 1 mL min−1. All the NSAIDs were well separated from each other and from diltiazem. Total run time was 10 min. The assay was successfully applied to pharmaceutical formulations and serum and there was no chromatographic interference from tablet excipients. The method was linear in the range 1.25–50 μg mL−1 both for diltiazem and the NSAIDs. The suitability of this HPLC method for quantitative analysis of the drugs was proved by validation in accordance with International Conference on Harmonization (ICH) guidelines. The validation results, and results from statistical analysis of the data, demonstrated the method was reliable.

Keywords

Column liquid chromatography Diltiazem Non-steroidal anti-inflammatory drugs (NSAIDs) Method validation 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgment

The authors are thankful to Higher Education Commission of Pakistan for financing this project.

References

  1. 1.
    Martindale (2005) The complete drug of reference, 34th edn. Pharmaceutical Press of Great Britain, pp 900–902Google Scholar
  2. 2.
    Buckley MMT, Grant SM, Goa KL, McTavish D, Sorkin EM (1990) Drugs 39:757–806CrossRefGoogle Scholar
  3. 3.
    Shinozuka T, Terada M, Ogamo A, Nakajima R, Takei S, Murai T, Wakasugi C, Yanagida J (1996) Jpn J Forensic Toxicol 14:246–252Google Scholar
  4. 4.
    Katzung BG (1995) Zakladní & klinická farmakologie (Basic & Clinical Pharmacology). H&H Jinočany, Jinočany, pp 517–520Google Scholar
  5. 5.
    Health Canada Guidance Documents (2006) Basic product monograph information for nonsteroidal anti-inflammatory drugs (NSAIDs), Drugs and health products, p 38Google Scholar
  6. 6.
    Johnson AG (1997) Drug Saf 17(5):277–289CrossRefGoogle Scholar
  7. 7.
    Baum C, Kennedy DL, Forbes MB (1985) Arthritis Rheum 28:686–692CrossRefGoogle Scholar
  8. 8.
    Roth SH (1988) J Rheumatol 15:912–919Google Scholar
  9. 9.
    Pavlicevic I, Rumboldt M, Rumboldt Z (2005) Lijec Vjesn 127(7/8):68–72Google Scholar
  10. 10.
    Chawla PS, Kochar MS (1999) WMJ 98(6):22–5, 29Google Scholar
  11. 11.
    Mene P, Pugliese F, Patrono C (1995) Semin Nephrol 15(3):244–252Google Scholar
  12. 12.
    Polonia J (1997) Cardiology 88(Suppl 3):47–51Google Scholar
  13. 13.
    Simons LS (1995) Curr Opin Rheumatol 7:159–166CrossRefGoogle Scholar
  14. 14.
    Meade EA, Smith WL, DeWitt DL (1993) J Biol Chem 268:6610–6614Google Scholar
  15. 15.
    MacFarlane LL, Orak DJ, Simpson WM (1995) Am Fam Physician 51:849–856Google Scholar
  16. 16.
    Harada Y, Kawamura M, Hatanaka K, Saito M, Ogino M, Ohno T, Ogino K, Yang Q (1998) Prostaglandins & other lipid mediators 55:345–358Google Scholar
  17. 17.
    Stillman MT, Schlesinger PA (1990) Arch Intern Med 150:268–270CrossRefGoogle Scholar
  18. 18.
    Sahloul MZ, al-Kiek R, Ivanovich P, Mujais SK (1990) Nephron 56:345–352CrossRefGoogle Scholar
  19. 19.
    Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA (1995) Pharmacol Rev 47:25–49Google Scholar
  20. 20.
    Shreedhar K, Sastry CSP, Reddy MN, Sankar DG (1995) Indian Drugs 32:90–92Google Scholar
  21. 21.
    Kamath BV, Shivram K (1991) Indian Drugs 29:50–52Google Scholar
  22. 22.
    Sultana N, Arayne MS, Shafi N (2007) Pak J Pharm Sci 20(4):279–284Google Scholar
  23. 23.
    Lacroix PM, Beaulieu N, Cyr TD, Lovering EG (1989) J Pharm Sci 78:243–246CrossRefGoogle Scholar
  24. 24.
    Sidhu AS, Kennedy JM, Deeble S (1987) J Chromatogr 391:233–242CrossRefGoogle Scholar
  25. 25.
    Dragica Z, Traje S, Marina S (2003) Anal Bioanal Chem 376:843–853Google Scholar
  26. 26.
    Li K, Xin Z, Zhao F (2003) Biomed Chromatogr 17(8):522–525CrossRefGoogle Scholar
  27. 27.
    Chaudhary RS, Gangwal SS, Avachat MK, Shah YN, Jindal KC (1993) J Chromatogr 614:261–266CrossRefGoogle Scholar
  28. 28.
    Shimizu R, Ishii K, Tsumagari N, Tanigawa M, Matsumoto M (1982) J Chromatogr A 253:101–108CrossRefGoogle Scholar
  29. 29.
    Shimizu R, Kakimoto T, Ishii K, Fujimoto Y, Kishi H, Tsumagari N (1986) J Chromatogr A 357:119–125CrossRefGoogle Scholar
  30. 30.
    Carignan G, Carrier K, Laganiere S, Lessard M (1995) J Chromatogr B 672:261–269CrossRefGoogle Scholar
  31. 31.
    Rouini MR, Asadipour A, Ardakani YH, Aghdasi F (2004) J Chromatogr B 800:189–192CrossRefGoogle Scholar
  32. 32.
    Nemutlu E, Sayın F, Başcı NE, Sedef K (2007) J Fac Pharm Hacettepe Univ 27(2):107–118Google Scholar
  33. 33.
    Chmielewska A, Konieczna L, Plenis A, Bieniecki M, Lamparczyk H (2005) Biomed Chromatogr 20(1):119–124CrossRefGoogle Scholar
  34. 34.
    Sajeev C, Jadhav PR, RaviShankar D, Saha RN (2002) Anal Chim Acta 463:207–217CrossRefGoogle Scholar
  35. 35.
    Miao XS, Koenig BG, Metcalfe ChD (2002) J Chromatogr A 952:139–147CrossRefGoogle Scholar
  36. 36.
    Abde-Hamid ME, Novotny L, Hamza H (2001) J Pharm Biomed Anal 24:587–594CrossRefGoogle Scholar
  37. 37.
    Battista HJ, Wehinger G, Henn R (1985) J Chromatogr 345:77–89CrossRefGoogle Scholar
  38. 38.
    Owen SG, Roberts MS, Friesen WT (1987) J Chromatogr 416:293–302CrossRefGoogle Scholar
  39. 39.
    Taylor MR, Westwood SA (1995) J Chromatogr A 697:389–396CrossRefGoogle Scholar
  40. 40.
    Hirai T, Matsumoto S, Kishi I (1997) J Chromatogr B 692:375–388CrossRefGoogle Scholar
  41. 41.
    Arcelloni C, Lanzi R, Pedercini S, Molteni G, Fermo I, Pontiroli A, Paroni R (2001) J Chromatogr B 763:195–200CrossRefGoogle Scholar
  42. 42.
    Martín MJ, Pablos F, González AG (1999) Talanta 49:453–459CrossRefGoogle Scholar
  43. 43.
    Rafifa H, Marie P (2006) J Pharm Biomed Anal 41:1463–1467CrossRefGoogle Scholar
  44. 44.
    Gonzalez G, Ventura R, Smith AK, Torre R, Segura J (1996) J Chromatogr A 719:251–264CrossRefGoogle Scholar
  45. 45.
    Rodríguez I, Carpinteiro J, Quintana JB, Carro AM, Lorenzo RA, Cela R (2004) J Chromatogr A 1024:1–8CrossRefGoogle Scholar
  46. 46.
    Koichi S, Lee WL, Toyohide T, Yasuhide S, Kiyohito S, Yuji T, Kanno S (2006) Anal Bioanal Chem 384:1501–1505CrossRefGoogle Scholar
  47. 47.
    Plackett RL, Burman JP (1943–1946) Biometrika 33:305–325Google Scholar
  48. 48.
    ASTM E (1169-89) Standard guide for conducting ruggedness tests (Plackett–Burman design). American Society for Testing and Materials, West Conshohocken, PA 19428-2959Google Scholar
  49. 49.
    Mehta AC (1997) Analyst 122:83RCrossRefGoogle Scholar

Copyright information

© Vieweg+Teubner | GWV Fachverlage GmbH 2009

Authors and Affiliations

  • Najma Sultana
    • 1
  • M. Saeed Arayne
    • 2
  • Nighat Shafi
    • 1
  • Farhan A. Siddiqui
    • 2
  1. 1.Research Institute of Pharmaceutical Sciences, Faculty of PharmacyUniversity of KarachiKarachiPakistan
  2. 2.Department of ChemistryUniversity of KarachiKarachiPakistan

Personalised recommendations